AlirezaAtriMDPhD
Neurosurgery • Boston, MA" Instructor in Neurology, Harvard Medical School Assistant in Neurology, Massachusetts General Hospital Director, Outpatient Memory Disorders & Dementia Units Associate Director, Clinical, GRECC, ENRM VA Medical Center "
Dr. Atri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15 Parkman St
Wac 830
Boston, MA 02114Phone+1 617-726-1728Fax+1 617-726-4101
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1998 - 2001- Brigham and Women's HospitalInternship, Internal Medicine, 1997 - 1998
University of California San Francisco School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 2015 - Present
AZ State Medical License 2018 - 2026
MA State Medical License 1999 - 2026- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 21 citationsValidity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimer's Disease: Comparison of Efficac...Alireza Atri, Susan Rountree, Oscar L. Lopez, Rachelle S. Doody
Neuro-Degenerative Diseases. 2012-02-10 - 56 citationsEffectiveness of antidementia drugs in delaying Alzheimer's disease progressionSusan Rountree, Alireza Atri, Oscar L. Lopez, Rachelle S. Doody
Alzheimer's & Dementia. 2013-05-01 - 150 citationsLong-term Course and Effectiveness of Combination Therapy in Alzheimer DiseaseAlireza Atri, Lynn W. Shaughnessy, Joseph J. Locascio, John H. Growdon
Alzheimer Disease and Associated Disorders. 2008-07-01
Press Mentions
Prothena to Highlight Next Generation Treatments for Alzheimer’s and Parkinson’s Disease at the AD/PD 2023 MeetingMarch 14th, 2023- Antipsychotic Shows Benefit for Alzheimer’s AgitationJune 12th, 2022
- Medicare Proposes Covering Expensive Alzheimer's Drug for Those in Clinical TrialsJanuary 11th, 2022
- Join now to see all
Grant Support
- Modeling Cholinergic Modulation Of FMRI Memory Networks In Aging &MciNational Institute On Aging2006–2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
